X

Xeris Biopharma Holdings
D

XERS

3.75500
USD
-0.22
(-5.53%)
Market Closed
Volume
64,933
EPS
-0
Div Yield
-
P/E
-9
Market Cap
559,800,886
OverviewSignalsIdeasNews
Related Instruments
    A
    ALDX
    -0.04000
    (-0.59%)
    6.69000 USD
    A
    AQST
    -0.05000
    (-1.63%)
    3.01500 USD
    B
    BHC
    0.13500
    (1.88%)
    7.31000 USD
    E
    EPIX
    -0.02500
    (-1.43%)
    1.72000 USD
    E
    ESPR
    -0.03500
    (-1.88%)
    1.82500 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    I
    INSM
    -2.480
    (-2.97%)
    81.040 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    R
    RDHL
    -0.08000
    (-1.64%)
    4.81000 USD
    S
    SAGE
    0.16000
    (2.24%)
    7.30500 USD
    More
News

Title: Xeris Biopharma Holdings

Sector: Healthcare
Industry: Biotechnology
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.